VXRT testing another familiar area of "traffic" from the last few months. This 786 fib area has remained a key level on the chart. More times than not, VXRT has failed to break and hold above it for any meaningful amount of time. But thanks to new covid cases and its recent business update, things are popping on Aug 9th. Though the volume isn't anything crazy...
Targeting 290 sometime during the month of August. I've seen lots get burned trying to short this stock, but I think it's primed for a pullback in the near term. Upcoming earnings will tell. NOTE: I'm pretty new to TA, but I like to think I've learned a good bit since I started. Any feedback would be welcomed. No offense taken.
WORX stock tested a key FIb level on Wednesday being the 50 fib line after plotting the top anchor at the recent high the first time WORX busted above the 50 fib. Before this latest round of testing, the last time WORX reached this key level it was rejected heavily. A few weeks ago, the company announced that it had regained compliance with the NASDAQ listing...
NRXP is in for a wild & volatile ride where it may reverse & double in value or even more. Technicals support a reversal over weeks with a current strong trend on the daily. Fundamentals are strong; F-Score is 9 & they just had some major news catalysts including a COVID-19 Treatment drug. High risk with potentially high reward: up to a 25% drawdown and a...
After strong Q1 and Q2 earnings. With fears of delta covid variant. It seems that Zoom stock is about start a bull cycle. Beside the strong fundamentals and supportive circumstances. This convintion is also build upon chart technicals where the price has broke through a falling channel, and now testing the upper trend + 50 day moving average. As shown the candle...
Biotech sector is getting hot, especially for companies connected to COVID-19 vaccine and treatments development... BIOV chart looks rip for a breakout with MACD closing in on bullish cross and a major catalyst in the form of FDA approval of its Phase I/II study: FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical...
On 6/15/2021 Cantor Fitzgerald brokerage Boosted the Price Target from Reduce to Overweight $217.00 to $272.00 On 5/18/2021 JPMorgan Chase & Co. brokerage Reiterated Rating from Overweight to Neutral $285.00 to $161.00 On 5/12/2021 B. Riley brokerage Lowered the Price Target from $365.00 to $286.00 On 5/12/2021 HC Wainwright brokerage Lowered the...
Etsy.... strong surge off support line from 160-170 ranges with a strong 30+ point breakout from June lows. Retraced perfectly to .618 (180) and bounce on the retest of downtrend break. 200 -> 208 -> 220 -> new highs.... If u missed the reversal on first post here it is again.
Model has given entry signals for CSL Limited: - CSL Limited is a global specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. - We are very excited about opportunities in the biotech sector, as we believe the fight against COVID is going to move to the next phase in...
Supposedly the beneficiary of the vaccine story as one of the appointees approved by the government. A duopoly with DPHARMA. However... their price & volume action is dimming fast.. The cup and handle pattern is invalidated. The recent decision to prioritize Pfizer vaccine over Sinovac really trigger a sell-down on PHARMA stock price with high volume. Expect...
I am looking at potential short positions on OIL related stocks as indicated by this example. Observation Phillips 66 has gone into a bearish mode with swing traders (around 30% of the market) losing on net longs positions with the wider market on average now being at break even. Break-even price levels can mean either 1) important support areas, 2) break...
APT - Here We Are Again pt.2? Mask Mandates Incoming... BUYING CALLS BUYZONE = 7 - 6.22 1st Target = 10.50 2nd Target = .236@14 ______________________________________________________________________________________________________________________ This content is for informational, educational and entertainment purposes only. This is not in any way, shape or...
KNR has been beaten down but looks way overdone, given they have just raised $8.5 at 1.50 with institutional investors. The company reported respectable $3.3M revenues in Q1 2021. Their BioCloud COVID-19 detection device will be used by the Canadian Olympic delegation at the Tokyo Olympics. The US sales channel is being worked on. Insiders are buying in the open...
Lots of bull... however, Due to "variants" OCGN has a solid bull case.. Waiting on Ken to put this price action into warp speed..... Trade safe! Smash that like button and follow for more!
UPI is ridiculously undervalued at $15M mkt cap and is a potential multi-bagger candidate from these levels. - Close to $10M in revenue in 2020 and is on pace to at least double it — recorded $1M in sales in the first week of June! - Profitable, no debt - Exclusive distributor of the 20-second non-invasive (finger scan) COVID-19 test that is currently undergoing...
My Watchlist: $JNCE $SRNE $SURF $UBX $BNTX $ZLAB $ATOS The bio market is getting hot again! Like and follow for more biotech ideas :) Happy Trading!
Novacyt big fall today, don't worry medium long term still hasn't broken level but keep an eye out for volatility next week we recommend that you buy if you can to the level you think is appropriate, it is a company that in the medium term has high expectations L.E.D Capital Management has investments and has had large investments in ALNOV, continuing to rely on...